Adel Rafai Far, Ph.D.Principal Fellow, Chemical and Analytical R&D at Novartis Pharmaceuticals
Adel Rafai Far, PhD, is a principal fellow, chemical and analytical R&D at Novartis Pharmaceuticals. Prior to joining Novartis, he was employed at The Medicines Company in for 11 years, leading to a position of senior director, drug substance development responsible for the development activities around the inclisiran drug substance, an siRNA designed to reduce LDL cholesterol. Prior to joining The Medicines Company, Adel was director, chemistry, at Targanta Therapeutics, a small company targeting the discovery and development of antibacterial agents. Dr. Rafai Far has a PhD in organic chemistry from the University of Toronto and was a post-doctoral fellow at the Scripps Research Institute.